Skip to main content
Cureus logoLink to Cureus
. 2021 Jul 22;13(7):e16573. doi: 10.7759/cureus.16573

Popliteal Pterygium With Van Der Woude Syndrome

Monica Dobs 1, Mohamed A Ghamry 2, Priyanka Anvekar 3,✉, Petras Lohana 4, Syed R Ali 5
Editors: Alexander Muacevic, John R Adler
PMCID: PMC8378313  PMID: 34430173

Abstract

Van der Woude syndrome (VWS) is an autosomal dominant syndrome due to mutation of a gene located in the long arm of chromosome 1 (1q32.3-q4) called the interferon regulatory factor-6 (IRF6) gene. VW syndrome-affected children are born with a cleft lip or palate, hypodontia (absent teeth), and bilateral paramedian lower-lip pits, which are usually moist because they are often associated with accessory salivary glands and mucous glands that empty into the pits. Popliteal pterygium syndrome (PPS), also known as a fasciogenito-popliteal syndrome or popliteal web syndrome is a rare autosomal dominant disorder with an incidence of approximately 1 in 300,000 live births. The most common clinical manifestations are popliteal webbing, cleft palate, cleft lip, syndactyly, and genital and nail anomalies. This report describes the clinical features in one case with positive family history, showing the range of anomalies found in popliteal pterygium with VWS.

Keywords: dysmorphic features, vw syndrome, irf6 gene, popliteal pterygium syndrome, fasciogenito-popliteal syndrome, popliteal web syndrome

Introduction

Van der Woude syndrome (VWS) is present in about 2% of all patients with cleft lip and/or palate with a prevalence of approximately 3.6/100,000 of live births. The bilateral, paramedian lower lip pits with or without cleft palate and/or lip is typical of this syndrome Patients commonly present with cleft lip, cleft lip, and palate or with cleft palate only. Popliteal pterygium syndrome (PPS) shares some features with VWS, but, in addition, has a characteristic cutaneous webbing or skin fold that extends from the ischium to the heel (“popliteal pterygium”), associated with toenail dysplasia, eventual foot and toes deformities, oral cavity, and genitourinary anomalies. VWS and PPS are autosomal dominantly inherited disorders caused by heterozygous mutations in the interferon regulatory factor-6 (IRF6) gene. In 68% of patients with VWS and 97% of patients with PPS, a heterozygous IRF6 mutation is detectable. We reported a case of a girl who has a manifestation of both syndromes which could probably support the hypothesis that both syndromes could represent variants of the same condition [1].

Case presentation

A five-year-old female patient presented to the pediatric emergency department with severe pallor. The patient was born full-term, normal vaginal delivery, conceived out of a consanguineous marriage. The patient has no history of NICU admissions in the past. Family history is positive for death in her sibling at the age of 3 due to pneumonia. There is also a history of no healthy living children. The patient’s parents decided to have no children in the future. On physical examination, she had deformities in both lower extremities and joints (Figure 1) and alopecia totalis (Figure 2).

Figure 1. Lower extremities deformities in the patient with Van der Woude syndrome.

Figure 1

Figure 2. Alopecia totalis and presence of nasogastric tube in the patient due to feeding difficulties.

Figure 2

She also had a cleft lip and cleft palate and there was a presence of nasogastric tube due to feeding difficulties because of her cleft palate and cleft lip (Figure 3). The patient was immediately admitted to the pediatric ward. Laboratory investigations on admission were as follows: hemoglobin (Hb): 4.2 g/dL (9.5-14 g/dL), red blood cells (RBC): 3 million cells/microlitre (3.5-5 million cells/microlitre), white blood cells (WBC): 7 x 109/litre (5-10 x 109/litre), platelet count: 584 x 109/litre (205-483 x 109/litre). Further investigation revealed mean corpuscular hemoglobin concentration (MCHC) 220 g/litre (320-360 g/litre), mean cell value (MCV) of 61.0 fL (74.5-93.9 fL), serum iron 2.1 μmol/L (8-24 μmol/L), serum total iron-binding capacity (TIBC) of 93.8 μmol/L (44-85 μmol/L), transferrin saturation of 23% (0.12-0.46%) and ferritin of 2.3 μg/L (12-270 μg/L), red cell distribution width (RDW) of 17% (11.6-14.8%). A review of other systems was within normal limits. Electrolytes, liver profile, bilirubin, and renal profile were normal. There were no signs of hemorrhage or hemolysis detected. The patient’s blood was sent for cross-matching and an arrangement for packed RBC for transfusion was made. Written consent was obtained from the parent and the patient was given 15mL/Kg of packed RBCs along with oxygen as supportive therapy. The patient tolerated the treatment well and was successfully stabilized. The patient’s Hb was rechecked after the treatment and it was 9.6 g/dL. She was discharged with the advice of regular follow-ups, dietary advice, and timely investigations. The parents were counseled about the patient’s prognosis and referred to speech therapy.

Figure 3. Cleft lip and cleft palate in the patient.

Figure 3

Discussion

PPS is a rare autosomal dominant disorder with an approximate incidence of 1 in 300,000 live births and shows both inter-and intrafamilial variation [2]. The term PPS was given by Gorlin in 1968 and was first described by Trelat in 1869 [3]. The percentage of presence of clinical manifestations are cleft palate (93%), popliteal webbing (58%), cleft lip (58%), lower lip pits (46%), syndactyly (50%), genital anomalies (37%), and nail anomalies (33%). Other rare reported clinical features include talipes, ankyloblepharon, syngnathia, and digital reduction defects. IQ is usually normal 2 but there is a risk of delayed language development, learning disabilities, and other mild cognitive problems [4]. PPS has a highly variable expression and incomplete penetrance. Genetic heterogeneity of environmental factors cannot be excluded in sporadic occurrences [3].

VWS is present in approximately 2% of all cleft patients. The bilateral paramedian lower lip pits with or without cleft lip and/or palate is typical of this syndrome and the pits have sinuses from salivary and mucous glands so they are usually discharged. Hypodontia is not rare in VWS, while single median salivary lower lip pit and unique single big tooth are rarely reported manifestations [3].

PPS and VWS are allelic variants of the same condition because they are caused by different mutations of the same gene. PPS includes all the features of VWS, plus popliteal pterygium, syndactyly, distinct toe/nail abnormality, syngnathia, and genitourinary malformations [5].

The cause of VWS is a mutation in the IRF6 gene of the long arm of chromosome 1 (1q32.3-q4). The gene is responsible for making a protein that plays an important role in early development and is active in cells that give rise to tissues in the head, face, skin, and genitals. The PPS is associated also with mutations in the IRF6 (1q32.2-q32.3) gene, involved in the formation of epithelial and connective tissues. Prognosis is depending on the severity of pterygium and genital anomalies may cause infertility otherwise prognosis of growth and intelligence is good [4].

Cleft lip and/or palate should be treated surgically at an early stage. Speech therapy, as well as audiological and dental assessments, should also be provided. The choice of treatment method for popliteal pterygium of PPS may be difficult, but in general surgical treatment is preferred because the conservative treatments, including serial casting or traction, have unsatisfactory outcomes. Among these surgical treatments, resection of fibrous bands and Z-plasty lead to a lengthening of the soft tissues such as the skin, muscles, and ligaments were the most preferred surgery. However, If the sciatic nerve is displaced into the webbing and it is attached to the fibrous tissues, this surgery will not be applicable and nerve grafting may be additionally needed. In severe cases, amputation may be the only option. Correction of deformities might be obtained with knee arthrodesis, femoral shortening, or femoral extension osteotomy [6]. 

Conclusions

This case of VWS and PPS is reported for its rarity and the high importance of detecting its features and support the affected children with suitable nutritional, medical and surgical treatment to improve their quality of life and health. Both syndromes have autosomal dominant inheritance and both have a mutation in gene IRF6. Both syndromes share common clinical manifestations as cleft lips and palate, pits on lower lips and palate, salivary gland and speaking problems, and others. PPS has an affection for extremities and external genitalia. Some anomalies especially face anomalies can be diagnosed early, in utero with ultrasound. Today, the prognosis and treatment of individuals with VWS are excellent. The prognosis of individuals with PPS will depend on severity.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Van der Woude and popliteal pterygium syndromes: broad intrafamilial variability in a three generation family with mutation in IRF6. Busche A, Hehr U, Sieg P, Gillessen-Kaesbach G. Am J Med Genet A. 2016;170:2404–2407. doi: 10.1002/ajmg.a.37791. [DOI] [PubMed] [Google Scholar]
  • 2.Popliteal pterygium syndrome: a clinical study of three families and report of linkage to the Van der Woude syndrome locus on 1q32. Lees MM, Winter RM, Malcolm S, Saal HM, Chitty L. https://pubmed.ncbi.nlm.nih.gov/10593995/ J Med Genet. 1999;36:888–892. [PMC free article] [PubMed] [Google Scholar]
  • 3.Van der woude and popliteal pterygium syndromes. Bennun RD, Stefano E, Moggi LE. J Craniofac Surg. 2018;29:1434–1436. doi: 10.1097/SCS.0000000000004698. [DOI] [PubMed] [Google Scholar]
  • 4.Mujezinović PM. 2017. A case of familial Van der Woude syndrome and Popliteal Pterygium syndrome. 16th World Congress in Fetal Medicine. [Google Scholar]
  • 5.An update on the aetiology of orofacial clefts. Wong FK, Hagg U. https://pubmed.ncbi.nlm.nih.gov/15479962/ Hong Kong Med J. 2004;10:331–336. [PubMed] [Google Scholar]
  • 6.Treatment of popliteal pterygium using an Ilizarov external fixator. Kim HM, Park IJ, Jeong C. Clin Orthop Surg. 2009;1:236–239. doi: 10.4055/cios.2009.1.4.236. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES